Search

Your search keyword '"tiagabine"' showing total 39 results
Start Over Descriptor "tiagabine" Publisher newsrx llc
39 results on '"tiagabine"'

1. New Gamma-aminobutyric Acid Reuptake Inhibitors Study Results from Cardiff University Described (Tiagabine Induced Modulation of Oscillatory Connectivity and Activity Match Pet-derived, Canonical Gaba-a Receptor Distributions)

Subjects
Flumazenil, Tiagabine, GABA, Physical fitness, Health, Cardiff University
Abstract

2021 SEP 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Gamma-aminobutyric Acid Reuptake [...]

Published
2021

2. New Parkinson's Disease Study Findings Have Been Reported from Xiang'an Hospital (Amelioration of olfactory dysfunction in a mouse model of Parkinson's disease via enhancing GABAergic signaling)

Subjects
Medical research, Medicine, Experimental, Movement disorders, Tiagabine, GABA, Health
Abstract

2023 JUN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Parkinson's disease have been published. According to news originating [...]

Published
2023

4. Electrophysiological receptor mapping of GABA-A receptors

Subjects
Brain, GABA, Physical fitness, Tiagabine, Flumazenil, Neurons, Obesity, Neurosciences, Editors, Health
Abstract

2020 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2020

5. Researchers Submit Patent Application, 'Method And Composition For Treating Epilepsy', for Approval (USPTO 20200129521)

Subjects
Physical fitness -- Methods, Anticonvulsants -- Intellectual property -- Methods, Brivaracetam -- Methods, Epilepsy -- Methods, Stiripentol, Primidone, Levetiracetam, Fosphenytoin, Methsuximide, Ezogabine, Oxcarbazepine, Obesity, Vigabatrin, Perampanel, Felbamate, Lacosamide, Lamotrigine, Zonisamide, Tiagabine, Editors, Health
Abstract

2020 MAY 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2020

6. Patent Issued for Topical Formulations Having Enhanced Bioavailability (USPTO 10,588,859)

Subjects
Miglitol -- Intellectual property, Clemastine -- Intellectual property, Nalbuphine -- Intellectual property, Rifapentine -- Intellectual property, Dirithromycin -- Intellectual property, Paricalcitol, Valsartan, Halofantrine -- Intellectual property, Metronidazole -- Intellectual property, Povidone -- Intellectual property, Efavirenz -- Intellectual property, Oxaprozin -- Intellectual property, Fenofibrate -- Intellectual property, Physical fitness, Cilostazol -- Intellectual property, Tizanidine -- Intellectual property, Anticonvulsants -- Intellectual property, Telmisartan -- Intellectual property, Butenafine -- Intellectual property, Zileuton -- Intellectual property, Sibutramine -- Intellectual property, Death, Obesity, Vigabatrin, Tiagabine, Editors, Lamotrigine, Health
Abstract

2020 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Berg LLC (Framingham, Massachusetts, United States) has been issued patent number 10,588,859, [...]

Published
2020

7. Reports Outline Gene Therapy Study Findings from University of Glasgow (Mechanisms of action of currently used antiseizure drugs)

Subjects
Physical fitness -- Reports -- Analysis, Genetic research -- Reports -- Analysis, Gene therapy -- Reports -- Analysis, Drugs -- Research -- Reports -- Analysis, Anticonvulsants -- Research -- Reports -- Analysis, Brivaracetam -- Research -- Reports -- Analysis, Epilepsy -- Research -- Reports -- Analysis, Seizures (Medicine) -- Research -- Reports -- Analysis, Anopheles, Levetiracetam, Finance, Biotechnology, Diseases, Ezogabine, Obesity, Vigabatrin, Perampanel, Lamotrigine, Tiagabine, Editors, Health, University of Glasgow -- Reports
Abstract

2020 MAR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Biotechnology - Gene Therapy is now available. According [...]

Published
2020

8. Researchers at University of Leuven (KU Leuven) Hospital Release New Data on Clinical Pharmacology (Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review)

Subjects
Benzodiazepines, Pharmacology, Physical fitness, Tiagabine, Drugs, Suvorexant, Ramelteon, Elderly, Medical research, Insomnia, Antianxiety agents, Obesity, Editors, Health
Abstract

2020 JAN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Clinical Pharmacology. According [...]

Published
2020

9. Researchers Submit Patent Application, 'Use Of Pridopidine For The Treatment Of Fragile X Syndrome', for Approval (USPTO 20190336488)

Subjects
Physical fitness, Anticonvulsants -- Intellectual property, Fragile X syndrome, Containers, Anopheles, Primidone, Disabilities, Autism, Obesity, Vigabatrin, Technology, Lamotrigine, Tiagabine, Editors, Health
Abstract

2019 NOV 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2019

10. Patent Issued for A19-144, A2-73 And Certain Anticholinesterase Inhibitor Compositions And Method For Anti-Seizure Therapy (USPTO 10,441,563)

Subjects
Glycoproteins, Physical fitness, Memantine -- Intellectual property, Anticonvulsants -- Intellectual property, Seizures (Medicine), Primidone, Levetiracetam, Rufinamide, Ethotoin, Oxcarbazepine, Obesity, Vigabatrin, Insurance industry, Perampanel, Felbamate, Phenacemide, Lacosamide, Lamotrigine, Zonisamide, Tiagabine, Editors, Health, Fycompa (Medication) -- Intellectual property
Abstract

2019 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a [...]

Published
2019

11. Findings from Maria Curie Sklodowska University Has Provided New Information about Cannabidiol (Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: ...)

Subjects
Physical fitness, Drugs, Anticonvulsants, Epilepsy -- Drug therapy, Seizures (Medicine) -- Drug therapy, Drug interactions, Levetiracetam, Cannabinoids, Phenols (Class of compounds), Oxcarbazepine, Obesity, Drug resistance, Lacosamide, Lamotrigine, Tiagabine, Editors, Health
Abstract

2019 AUG 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Cannabinoids - Cannabidiol. According to news originating [...]

Published
2019

12. Patent Application Titled 'Compositions And Methods For Increasing Insulin Sensitivity' Published Online (USPTO 20190231852)

Subjects
Lofexidine -- Methods -- Intellectual property, Trimipramine -- Methods -- Intellectual property, Anticonvulsants -- Methods -- Intellectual property, Aripiprazole -- Methods -- Intellectual property, Type 2 diabetes -- Methods, Insulin -- Methods -- Intellectual property, Narcotic antagonists -- Methods -- Intellectual property, Women's health, Levetiracetam, Fosphenytoin, Methsuximide, Alvimopan, Oxcarbazepine, Felbamate, Nalmefene, Methylnaltrexone, Lamotrigine, Zonisamide, Tiagabine, Editors, Hypoglycemic agents, Health, Women's issues/gender studies
Abstract

2019 AUG 22 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2019

13. New Epilepsy Study Findings Recently Were Reported by Researchers at Medical University of Plovdiv (Paradoxical Seizure Aggravation Caused By Newer-generation Aeds In Bulgarian Patients With Drug-resistant Epilepsy)

Subjects
Physical fitness -- Reports, Anticonvulsants -- Research -- Reports, Epilepsy -- Drug therapy -- Research -- Reports, Drug resistance -- Drug therapy -- Research -- Reports, Medical research -- Reports, Seizures (Medicine) -- Drug therapy -- Research -- Reports, Levetiracetam, Oxcarbazepine, Obesity, Lacosamide, Lamotrigine, Tiagabine, Editors, Central nervous system, Health
Abstract

2019 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Central Nervous System Diseases and Conditions - Epilepsy is [...]

Published
2019

14. Patent Application Titled 'Methods And Compositions For Treating And Preventing Trigeminal Autonomic Cephalgias, Migraine, And Vascular Conditions' Published Online (USPTO 20190105290)

Subjects
Duloxetine -- Intellectual property -- Methods, Almotriptan -- Intellectual property -- Methods, Tiotropium -- Intellectual property -- Methods, Memantine -- Intellectual property -- Methods, Pindolol -- Intellectual property -- Methods, Physical fitness -- Methods, Esmolol -- Intellectual property -- Methods, Eletriptan -- Intellectual property -- Methods, Pseudoephedrine -- Intellectual property -- Methods, Migraine -- Methods, Anticonvulsants -- Intellectual property -- Methods, Antihistamines -- Intellectual property -- Methods, Obesity, Felbamate, Carbinoxamine, Primidone, Editors, Tiagabine, Zonisamide, Lamotrigine, Levetiracetam, Clemastine, Pyrilamine, Tripelennamine, Brompheniramine, Health
Abstract

2019 MAY 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2019

15. Findings from University of Auckland Broaden Understanding of Neuroimaging (1/f Electrophysiological Spectra In Resting and Drug-induced States Can Be Explained By the Dynamics of Multiple Oscillatory Relaxation Processes)

Subjects
Electrophysiologic tests -- Usage, Arrhythmia -- Research, Obesity, Tiagabine, Diagnostic imaging, Physical fitness, Medical imaging equipment, Neurophysiology, Perampanel, Editors, Health
Abstract

2019 APR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Medical Imaging - Neuroimaging are discussed in a new [...]

Published
2019

16. Patent Application Titled 'Use Of Mavoglurant In The Reduction Of Cocaine Use Or In Preventing Relapse Into Cocaine Use' Published Online (USPTO 20210093609)

Subjects
Novartis AG, Aripiprazole, Eating disorders, Mental health, Tiagabine, Pharmaceutical industry, Health, Psychology and mental health
Abstract

2021 APR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2021

18. Researchers Submit Patent Application, 'Use Of Cannabinoids In The Treatment Of Epilepsy', for Approval (USPTO 20200138738)

Subjects
Anticonvulsants -- Reports, Cannabinoids -- Reports, Epilepsy -- Reports, Stiripentol, Cannabidiol, Primidone, Levetiracetam, Phenols (Class of compounds), Rufinamide, Oxcarbazepine, Vigabatrin, Perampanel, Felbamate, Lacosamide, Lamotrigine, Zonisamide, Tiagabine, Editors, Business, Health
Abstract

2020 MAY 29 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2020

19. Researchers Submit Patent Application, 'A19-144, A2-73 And Certain Anticholinesterase Inhibitor Compositions And Method For Anti-Seizure Therapy', for Approval (USPTO 20200038365)

Subjects
Glycoproteins, Memantine -- Intellectual property, Anticonvulsants -- Intellectual property, Seizures (Medicine), Stiripentol, Acetylcholine, Primidone, Levetiracetam, Rufinamide, Biotechnology, Ethotoin, Oxcarbazepine, Vigabatrin, Insurance industry, Perampanel, Felbamate, Phenacemide, Lacosamide, Lamotrigine, Zonisamide, Tiagabine, Editors, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 FEB 26 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Missling, Christopher [...]

Published
2020

20. Patent Issued for Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders (USPTO 10,493,053)

Subjects
Anticonvulsants -- Intellectual property -- Methods, Doxepin -- Intellectual property -- Methods, Mental health -- Methods, Hypnotics and sedatives -- Intellectual property -- Methods, Sleep disorders -- Methods, Oxazepam -- Intellectual property -- Methods, Antimanic agents -- Intellectual property -- Methods, Central nervous system depressants, Ramelteon, Zaleplon, Vigabatrin, Eplivanserin, Eszopiclone, Lamotrigine, Flurazepam, Tiagabine, Editors, Health, Psychology and mental health
Abstract

2019 DEC 16 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent by the inventors Dube, Susan E. (Carlsbad, CA); Kavey, Neil B. [...]

Published
2019

21. Researchers at Uniformed Services University of the Health Sciences Release New Data on Gamma-aminobutyric Acid Reuptake Inhibitors (Increased Antiseizure Effectiveness With Tiagabine Combined With Sodium Channel Antagonists In Mice Exposed To ...)

Subjects
Lamotrigine, GABA, Tiagabine, Combination drug therapy, Seizures (Medicine), Convulsions, Editors, Anticonvulsants, Central nervous system, Health
Abstract

2019 DEC 6 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Drugs and Therapies - Gamma-aminobutyric Acid Reuptake Inhibitors. [...]

Published
2019

22. 'Transdermal Drug Delivery Devices And Methods' in Patent Application Approval Process (USPTO 20190336738)

Subjects
Nabilone -- Methods, Platelet aggregation inhibitors -- Intellectual property -- Methods, Lisdexamfetamine -- Methods, Suvorexant -- Intellectual property -- Methods, Amoxapine -- Intellectual property -- Methods, Lorcaserin -- Methods, Antimanic agents -- Intellectual property -- Methods, Febuxostat -- Methods, Droxidopa -- Methods, Memantine -- Intellectual property -- Methods, Anticonvulsants -- Intellectual property -- Methods, Antipsychotic agents -- Methods, Hypnotics and sedatives -- Intellectual property -- Methods, Antiparkinson agents -- Methods, Dolasetron -- Intellectual property -- Methods, Tasimelteon -- Methods, Pamidronate -- Intellectual property -- Methods, Dopamine agonists -- Methods, Bupivacaine -- Intellectual property -- Methods, Trimipramine -- Intellectual property -- Methods, Transdermal drug delivery systems -- Intellectual property -- Methods, Oxaprozin -- Intellectual property -- Methods, Tiotropium -- Intellectual property -- Methods, Acamprosate -- Intellectual property -- Methods, Antidepressants -- Intellectual property -- Methods, Armodafinil -- Methods, Zileuton -- Intellectual property -- Methods, Almotriptan -- Intellectual property -- Methods, Eletriptan -- Intellectual property -- Methods, Opioids -- Methods, Duloxetine, Loxapine, Sufentanil, Vortioxetine, Tapentadol, Rufinamide, Ezogabine, Brexpiprazole, Perampanel, Tirofiban, Clopidogrel, Tiagabine, Editors, Rasagiline, Levetiracetam, Remifentanil, Ramelteon, Oxcarbazepine, Ropinirole, Levomilnacipran, Lamotrigine, Entacapone, Drug delivery systems, Cabergoline, Biotechnology, Zaleplon, Vigabatrin, Eszopiclone, Tolcapone, Escitalopram, Lacosamide, Zonisamide, Alfentanil, Pramipexole, Vilazodone, Milnacipran, Fosphenytoin, Aripiprazole, Felbamate, Asenapine, Rotigotine, Prasugrel, Desvenlafaxine, Biotechnology industry, Biological sciences, Business
Abstract

2019 NOV 25 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- A patent application by the inventors JOHNSTON, Andrew L. (Redwood City, CA); SCHALLER, Michael [...]

Published
2019

23. 'Methods Of Treating Developmental Disorders With Gaboxadol' in Patent Application Approval Process (USPTO 20190321342)

Subjects
Memantine -- Methods -- Intellectual property, Anticonvulsants -- Methods -- Intellectual property, Autism -- Methods, Mental health -- Methods, Vigabatrin, Pyridine, Anopheles, Primidone, CAT scans, Alkaloids, Tiagabine, Editors, Health, Psychology and mental health
Abstract

2019 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent application by the inventor DURING, Matthew (Weston, CT), filed on June [...]

Published
2019

24. Patent Application Titled 'Therapeutic Approaches For Treating Alzheimer Disease And Related Disorders Through A Modulation Of Synapse Function' Published Online (USPTO 20190298698)

Subjects
Pegaptanib -- Intellectual property, Cinacalcet -- Intellectual property, Desirudin -- Intellectual property, Cilostazol -- Intellectual property, Argatroban -- Intellectual property, Anticonvulsants -- Intellectual property, Acamprosate -- Intellectual property, Mental health, Alendronate -- Intellectual property, Eletriptan -- Intellectual property, Alzheimer's disease, Alfentanil -- Intellectual property, Dasatinib, Anopheles, Fosphenytoin, Vigabatrin, Zonisamide, Tiagabine, Editors, Health, Psychology and mental health
Abstract

2019 OCT 21 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2019

25. Patent Issued for Methods Of Treating Developmental Disorders And/Or Seizure Disorders With Etifoxine (USPTO 10,420,773)

Subjects
Memantine -- Methods -- Intellectual property, Anticonvulsants -- Methods -- Intellectual property, Autism -- Methods, Mental health -- Methods, Seizures (Medicine) -- Methods, Fragile X syndrome, Vigabatrin, Primidone, Health, Tiagabine, Editors, Rett syndrome, Health, Psychology and mental health
Abstract

2019 OCT 7 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent by the inventor During, Matthew (Weston, CT), filed on April 24, [...]

Published
2019

26. Patent Issued for Tetrahydropyridopyrazine Modulators Of GPR6 (USPTO 10,406,157)

Subjects
Rotigotine -- Intellectual property, Trimipramine -- Intellectual property, Nonsteroidal anti-inflammatory agents, Amoxapine -- Intellectual property, Safinamide -- Intellectual property, Oxazepam -- Intellectual property, Antimanic agents -- Intellectual property, Memantine -- Intellectual property, Anticonvulsants -- Intellectual property, Antipsychotic agents, Antidepressants -- Intellectual property, Mental health, Hypnotics and sedatives -- Intellectual property, Antiparkinson agents, Duloxetine, Primidone, Health, Rufinamide, Zaleplon, Vigabatrin, Escitalopram, Eszopiclone, Tolcapone, Perampanel, Meclofenamate, Diflunisal, Lacosamide, Zonisamide, Tiagabine, Editors, Pramipexole, Lurasidone, Vilazodone, Rasagiline, Levetiracetam, Aripiprazole, Oxaprozin, Iloperidone, Oxcarbazepine, Paliperidone, Ropinirole, Asenapine, Fenoprofen, Lamotrigine, Flurazepam, Sulindac, Phenylbutazone, Desvenlafaxine, Entacapone, Health, Psychology and mental health
Abstract

2019 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent [...]

Published
2019

27. 'Methods Of Treating Developmental Disorders With Gaboxadol' in Patent Application Approval Process (USPTO 20190255027)

Subjects
Memantine -- Methods -- Intellectual property, Anticonvulsants -- Methods -- Intellectual property, Autism -- Methods, Mental health -- Methods, Vigabatrin, Pyridine, Anopheles, Primidone, CAT scans, Alkaloids, Tiagabine, Editors, Health, Psychology and mental health
Abstract

2019 SEP 9 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent application by the inventor DURING, Matthew (Weston, CT), filed on May [...]

Published
2019

28. Patent Application Titled 'Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders' Published Online (USPTO 20190231734)

Subjects
Anticonvulsants -- Methods -- Intellectual property, Doxepin -- Methods -- Intellectual property, Mental health -- Methods, Hypnotics and sedatives -- Methods -- Intellectual property, Sleep disorders -- Methods, Oxazepam -- Methods -- Intellectual property, Antimanic agents -- Methods -- Intellectual property, Central nervous system depressants, Ramelteon, Zaleplon, Vigabatrin, Eplivanserin, Eszopiclone, Lamotrigine, Flurazepam, Tiagabine, Editors, Health, Psychology and mental health
Abstract

2019 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2019

29. Patent Issued for Therapeutic Approaches For Treating Alzheimer Disease And Related Disorders Through A Modulation Of Synapse Function (USPTO 10,350,195)

Subjects
Pegaptanib -- Intellectual property -- Reports, Cinacalcet -- Intellectual property -- Reports, Desirudin -- Intellectual property -- Reports, Cilostazol -- Intellectual property -- Reports, Argatroban -- Intellectual property -- Reports, Anticonvulsants -- Intellectual property -- Reports, Acamprosate -- Intellectual property -- Reports, Mental health -- Reports, Alendronate -- Intellectual property -- Reports, Eletriptan -- Intellectual property -- Reports, Alzheimer's disease -- Reports, Alfentanil -- Intellectual property -- Reports, Dasatinib -- Reports, Anopheles, Fosphenytoin, Vigabatrin, Zonisamide, Tiagabine, Editors, Health, Psychology and mental health
Abstract

2019 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Cohen, [...]

Published
2019

30. Patent Application Titled 'Substituted Triazoles And Methods Relating Thereto' Published Online (USPTO 20190169137)

Subjects
Neurocrine Biosciences Inc. -- Intellectual property, Anticonvulsants -- Methods, Biotechnology industries -- Intellectual property -- Methods, Mental health -- Methods, Triazoles -- Methods, Disclosure of information, Primidone, Levetiracetam, Fosphenytoin, Health, Vigabatrin, Lacosamide, Lamotrigine, Zonisamide, Tiagabine, Editors, Health, Psychology and mental health
Abstract

2019 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2019

31. Researchers Submit Patent Application, 'Infusing Drug Solution Directly Into Brain Fluid', for Approval (USPTO 20190151239)

Subjects
Anticonvulsants -- Intellectual property, Drug approval, Antibacterial agents -- Intellectual property, Disclosure of information, Levetiracetam, Lamotrigine, Biotechnology, Tiagabine, Editors, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2019 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Abrams, Daniel [...]

Published
2019

32. 'Methods Of Treating Developmental Disorders With Gaboxadol' in Patent Application Approval Process (USPTO 20190117632)

Subjects
Autism -- Methods, Memantine -- Intellectual property -- Methods, Mental health -- Methods, Anticonvulsants -- Intellectual property -- Methods, Tiagabine, Alkaloids, Vigabatrin, Pyridine, CAT scans, Anopheles, Primidone, Editors, Health, Psychology and mental health
Abstract

2019 MAY 13 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent application by the inventor DURING, Matthew (Weston, CT), filed on December [...]

Published
2019

33. Researchers Submit Patent Application, 'Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders', for Approval (USPTO 20190099396)

Subjects
Sleep disorders -- Methods, Mental health -- Methods, Oxazepam -- Intellectual property -- Methods, Doxepin -- Intellectual property -- Methods, Antimanic agents -- Intellectual property -- Methods, Anticonvulsants -- Intellectual property -- Methods, Hypnotics and sedatives -- Intellectual property -- Methods, Zaleplon, Vigabatrin, Eplivanserin, Editors, Tiagabine, Central nervous system depressants, Lamotrigine, Flurazepam, Ramelteon, Eszopiclone, Health, Psychology and mental health
Abstract

2019 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2019

34. Patent Issued for Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders (USPTO 10,251,859)

Subjects
Sleep disorders -- Methods, Mental health -- Methods, Oxazepam -- Intellectual property -- Methods, Doxepin -- Intellectual property -- Methods, Antimanic agents -- Intellectual property -- Methods, Anticonvulsants -- Intellectual property -- Methods, Hypnotics and sedatives -- Intellectual property -- Methods, Zaleplon, Vigabatrin, Eplivanserin, Editors, Tiagabine, Central nervous system depressants, Lamotrigine, Flurazepam, Ramelteon, Eszopiclone, Health, Psychology and mental health
Abstract

2019 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent by the inventors Dube, Susan E. (Carlsbad, CA); Kavey, Neil B. [...]

Published
2019

35. Patent Application Titled 'Methods Of Treating Developmental Disorders And/Or Seizure Disorders With Etifoxine' Published Online (USPTO 20190091231)

Subjects
Autism -- Methods, Memantine -- Methods -- Intellectual property, Mental health -- Methods, Seizures (Medicine) -- Methods, Anticonvulsants -- Methods -- Intellectual property, Tiagabine, Fragile X syndrome, Vigabatrin, CAT scans, Rett syndrome, Health, Primidone, Editors, Health, Psychology and mental health
Abstract

2019 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2019

36. 'Formulation For Inhibiting Formation Of 5-Ht2b Agonists And Methods Of Using Same' in Patent Application Approval Process (USPTO 20190083425)

Subjects
Drug discovery -- Methods, Brivaracetam -- Methods, Epilepsy -- Methods, Anticonvulsants -- Intellectual property -- Methods, Ethotoin, Vigabatrin, Mephenytoin, Felbamate, Rufinamide, Primidone, Perampanel, Editors, Phenacemide, Lacosamide, Tiagabine, Oxcarbazepine, Zonisamide, Methsuximide, Pharmaceuticals and cosmetics industries
Abstract

2019 APR 12 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A patent application by the inventors FARR, Stephen J. (Orinda, CA); BOYD, BROOKS (Berkeley, CA), [...]

Published
2019

37. Patent Application Titled 'Formulation For Inhibiting Formation Of 5-Ht2b Agonists And Methods Of Using Same' Published Online (USPTO 20190083424)

Subjects
Drug discovery -- Methods, Brivaracetam -- Methods, Epilepsy -- Methods, Anticonvulsants -- Intellectual property -- Methods, Ethotoin, Vigabatrin, Mephenytoin, Felbamate, Rufinamide, Primidone, Perampanel, Editors, Phenacemide, Lacosamide, Tiagabine, Oxcarbazepine, Zonisamide, Methsuximide, Health
Abstract

2019 APR 8 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2019

38. Researchers Submit Patent Application, 'Methods Of Treating Behavioral Syndromes Using Pipradrol', for Approval (USPTO 20190076415)

Subjects
Attention deficit hyperactivity disorder -- Reports -- Methods, Mental health -- Reports -- Methods, Anticonvulsants -- Intellectual property -- Reports -- Methods, Vigabatrin, CAT scans, Central nervous system, Phenols (Class of compounds), Rufinamide, Primidone, Perampanel, Editors, Lacosamide, Tiagabine, Oxcarbazepine, Zonisamide, Lamotrigine, Marketing, Health, Psychology and mental health
Abstract

2019 APR 1 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor [...]

Published
2019

39. Researchers Submit Patent Application, 'Methods Of Treating Developmental Disorders With Biguanides', for Approval (USPTO 20190046480)

Subjects
Memantine -- Methods -- Intellectual property, Diabetes therapy -- Methods -- Intellectual property, Metformin -- Methods -- Intellectual property, Anticonvulsants -- Methods -- Intellectual property, Tiagabine, Mental health, Vigabatrin, CAT scans, Health, Primidone, Editors, Glucose, Health, Psychology and mental health
Abstract

2019 MAR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results